Merck CEO Sees More Drug-Industry Consolidation
By Peter Loftus
Merck CEO Ken Frazier said today that there could be further consolidation in pharmaceutical industry because of pressures on drug pricing and ever-rising research costs.
“I think there’s a certain redundancy of infrastructure in this industry,” he told a Goldman Sachs conference.
http://blogs.wsj.com/deals/2013/01/03/merck-ceo-sees-more-drug-industry-consolidation/?mod=MarketsMain
No comments:
Post a Comment